Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

about

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

Item

http://www.wikidata.org/entity/Q37060391

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

@en

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases.

@nl

type

Item

label

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

@en

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases.

@nl

prefLabel

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

@en

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases.

@nl

P1476

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

@en

P2093

Chang-Gong Zhang

http://www.w3.org/2001/XMLSchema#string

Jian-Ping Xu

http://www.w3.org/2001/XMLSchema#string

Lin Wang

http://www.w3.org/2001/XMLSchema#string

Sheng Yang

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Liu

http://www.w3.org/2001/XMLSchema#string

Yuan-Kai Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.

Incidence of brain metastasis at initial presentation of lung cancer.

Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma.

Current management of brain metastases, with a focus on systemic options.

Lung cancer incidence and mortality in China, 2011.

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer

A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320

P304

437-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1759-7714.12351

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27385986

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

4930963

http://www.w3.org/2001/XMLSchema#string